Oscar Health, Inc. (OSCR)
NYSE:OSCR
Want to see OSCR full AI Analyst Report?
OSCR Stock Chart & Stats
$15.79
$0.74(5.14%)
At close: 4:00 PM EST
$15.79
$0.74(5.14%)
Day’s Range― - ―
52-Week Range$10.69 - $29.81
Previous CloseN/A
Volume1.52M
Average Volume (3M)8.22M
Market Cap
$8.56B
Enterprise Value$2.96B
Total Cash (Recent Filing)$6.80B
Total Debt (Recent Filing)$430.88M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Aug 06, 2026EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding265,902,000
10 Day Avg. Volume7,732,087
30 Day Avg. Volume8,215,704
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.86
Price to Sales (P/S)0.32
P/FCF Ratio3.56
Enterprise Value/Market Cap0.35
Enterprise Value/Revenue0.22
Enterprise Value/Gross Profit1.28
Enterprise Value/Ebitda153.68
Forecast
1Y Price Target
$20.71Price Target Upside31.19% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1
Revenue Forecast (FY)$18.71B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationSustained, multi‑quarter free cash flow near $2.8B provides durable internal funding for claims volatility, reserve builds, tech investment and distribution scaling. Strong cash conversion improves financial flexibility and reduces reliance on external financing for strategic initiatives.
Improving Balance Sheet And Capital PositionMaterial equity expansion and lower debt/equity increase solvency headroom and insurer statutory capital flexibility, allowing Oscar to underwrite growth, absorb reserve variability and comply with regulatory capital tests while supporting product rollouts and provider relationships.
Rapid, Scalable Membership And Revenue GrowthLarge, sustained membership expansion increases premium base and fixed-cost leverage, lowering SG&A ratio and improving unit economics over time. Scale strengthens negotiating leverage with providers and distribution partners, supporting longer‑term margin improvement and market share.
Bears Say
Risk Adjustment VolatilityMaterial swings in ACA risk adjustment create persistent timing and earnings volatility, complicating underwriting predictability. Elevated RA can materially affect revenue and MLR across quarters, forcing conservative reserving or capital buffers that weigh on durable profitability metrics.
Inconsistent Profitability And Thin MarginsDespite recent improvement, oscillating net results and near‑breakeven operating margins indicate underwriting returns are not yet resilient. Durable earnings require consistent medical loss control and stable morbidity; continued inconsistency raises execution risk for sustained positive ROE.
Membership Churn And Seasonality Of PaymentsHigh initial enrollments with meaningful non‑payment and expected reversion toward pre‑ARPA churn reduce realized premium and complicate retention economics. Seasonality in claims further clouds forecasting, making durable revenue and loss‑ratio trends harder to rely on without improved payment effectuation.
Oscar Health News
OSCR FAQ
What was Oscar Health, Inc.’s price range in the past 12 months?
Oscar Health, Inc. lowest stock price was $10.69 and its highest was $29.81 in the past 12 months.
What is Oscar Health, Inc.’s market cap?
Oscar Health, Inc.’s market cap is $8.56B.
When is Oscar Health, Inc.’s upcoming earnings report date?
Oscar Health, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 46 days.
How were Oscar Health, Inc.’s earnings last quarter?
Oscar Health, Inc. released its earnings results on May 06, 2026. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.108 by $0.962.
Is Oscar Health, Inc. overvalued?
According to Wall Street analysts Oscar Health, Inc.’s price is currently Undervalued.
Does Oscar Health, Inc. pay dividends?
Oscar Health, Inc. does not currently pay dividends.
What is Oscar Health, Inc.’s EPS estimate?
Oscar Health, Inc.’s EPS estimate is 0.38.
How many shares outstanding does Oscar Health, Inc. have?
Oscar Health, Inc. has 265,902,000 shares outstanding.
What happened to Oscar Health, Inc.’s price movement after its last earnings report?
Oscar Health, Inc. reported an EPS of $2.07 in its last earnings report, beating expectations of $1.108. Following the earnings report the stock price went up 10.591%.
Which hedge fund is a major shareholder of Oscar Health, Inc.?
Currently, no hedge funds are holding shares in OSCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oscar Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$20.71 (31.19% Upside)
$20.71 (31.19% Upside)
Blogger Sentiment
Bullish
OSCR Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 676.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $11.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
51.30%
12-Months-Change
Fundamentals
Return on Equity
-3.27%
Trailing 12-Months
Asset Growth
61.72%
Trailing 12-Months
Company Description
Oscar Health, Inc.
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
OSCR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated robust top-line growth, record membership, strong profitability and a healthy balance sheet, with management highlighting AI/product initiatives and new distribution channels (Lucie, ICHRA X). Primary near-term concerns center on elevated early-year risk adjustment, seasonally low claims that affect RA and revenue timing, some prior-period reserve variability, and expected churn normalization. Management expressed confidence—reaffirming full-year guidance—and emphasized improving visibility after Q2 claims and Wakely reports.View all OSCR earnings summariesOSCR Stock 12 Month Forecast
Average Price Target
$20.71
▲(31.19% Upside)
Technical Analysis
Centene
―
Humana
―
Molina Healthcare
―
Clover Health Investments
―
Alignment Healthcare
―
Ownership Overview
5.45% Insiders
16.77% Mutual Funds
18.28% Other Institutional Investors
42.41% Public Companies and Individual Investors